Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.
AIMS: Missed diagnosis of maturity-onset diabetes of the young (MODY) has led to an interest in biomarkers that enable efficient prioritization of patients for definitive molecular testing. Apolipoprotein M (apoM) was suggested as a biomarker for hepatocyte nuclear factor 1 alpha (HNF1A)-MODY becaus...
Hlavní autoři: | Mughal, SA, Park, R, Nowak, N, Gloyn, A, Karpe, F, Matile, H, Malecki, M, McCarthy, M, Stoffel, M, Owen, K |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2013
|
Podobné jednotky
-
No attenuation of CRP response to acute inflammation is seen in HNF1A-MODY
Autor: Owen, K, a další
Vydáno: (2013) -
HNF1A-MODY is associated with an intact CRP response during human endotoxaemia
Autor: Mughal, SA, a další
Vydáno: (2014) -
High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
Autor: McDonald, T, a další
Vydáno: (2011) -
High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
Autor: McDonald, T, a další
Vydáno: (2011) -
Altered cortisol metabolism in individuals with HNF1A-MODY
Autor: Juszczak, A, a další
Vydáno: (2020)